MICHAEL FRUMOVITZ to Carcinoma, Neuroendocrine
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Carcinoma, Neuroendocrine.
Connection Strength
8.255
-
Neuroendocrine neoplasms of the ovary: a review of 63 cases. Int J Gynecol Cancer. 2024 Apr 01; 34(4):566-573.
Score: 0.588
-
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
Score: 0.572
-
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer. 2023 09 04; 33(9):1359-1369.
Score: 0.565
-
Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix. Int J Gynecol Cancer. 2023 04 03; 33(4):623-627.
Score: 0.549
-
The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol Oncol. 2023 03; 170:328-332.
Score: 0.543
-
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. J Gynecol Oncol. 2023 07; 34(4):e50.
Score: 0.543
-
Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2022 11 07; 32(11):1469-1474.
Score: 0.534
-
Early-stage, high-grade neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2021 08; 31(8):1179-1183.
Score: 0.489
-
Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix. Int J Gynecol Cancer. 2020 09; 30(9):1303-1307.
Score: 0.456
-
Comparative genomics of high grade neuroendocrine carcinoma of the cervix. PLoS One. 2020; 15(6):e0234505.
Score: 0.452
-
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol. 2020 09; 158(3):570-575.
Score: 0.452
-
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2017 Jan; 144(1):46-50.
Score: 0.352
-
Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557.
Score: 0.349
-
Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol Oncol. 2016 06; 141(3):588-591.
Score: 0.339
-
Small- and Large-Cell Neuroendocrine Cervical Cancer. Oncology (Williston Park). 2016 Jan; 30(1):70, 77-8, 93.
Score: 0.332
-
Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther. 2015; 15(7):805-10.
Score: 0.318
-
Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53.
Score: 0.285
-
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities. Clin Cancer Res. 2024 Oct 15; 30(20):4743-4754.
Score: 0.153
-
Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study. Int J Gynecol Cancer. 2024 Feb 05; 34(2):209-215.
Score: 0.145
-
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. Endocr Relat Cancer. 2023 08 01; 30(8).
Score: 0.140
-
Imaging and staging of neuroendocrine cervical cancer. Abdom Radiol (NY). 2018 12; 43(12):3468-3478.
Score: 0.102